SCHEMBL1110180

SCHEMBL1110180

O=C(Nc1ccccc1NC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 1/20 0.73
TP53 P04637 1/20 0.73
HDAC3 O15379 1/20 0.73
MAPK1 P28482 1/20 0.73
HDAC1 Q13547 1/20 0.73
HDAC2 Q92769 1/20 0.73
POLB P06746 1/20 0.73
HPGD P15428 1/20 0.73
KMT2A Q03164 5/20 0.69
MEN1 O00255 4/20 0.69
NPC1 O15118 2/20 0.68
RAB9A P51151 2/20 0.68
CYP1A2 P05177 1/20 0.68
CYP3A4 P08684 1/20 0.68
CYP2D6 P10635 1/20 0.68
CYP2C9 P11712 1/20 0.68
CYP2C19 P33261 1/20 0.68
MAPT P10636 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
PKM P14618 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10953014 0.93 HDAC3 (0.71) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL27645638 0.89 POLB (0.67) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL19509669 0.89 HDAC3 (0.66) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL6067716 0.89 HDAC1 (0.66) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL6140750 0.88 SIRT2 (0.59) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL6288808 0.87 HDAC3 (0.63) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL3148472 0.87 NPC1 (0.82) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL1470784 0.87 NPC1 (0.73) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL1490917 0.87 MDM4 (0.63) MDM4TP53HDAC3MAPK1HDAC1
SCHEMBL4946074 0.87 NPC1 (0.73) MDM4TP53HDAC3MAPK1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9896465-B2 Phosphonium compound, preparation method thereof, epoxy resin composition including the same, and semiconductor device prepared by using the same SAMSUNG SDI CO., LTD. (KR) 2018-02-20 US claimed
US-20160368937-A1 PHOSPHONIUM COMPOUND, PREPARATION METHOD THEREOF, EPOXY RESIN COMPOSITION INCLUDING THE SAME, AND SEMICONDUCTOR DEVICE PREPARED BY USING THE SAME SAMSUNG SDI CO., LTD. (KP) 2016-12-22 US claimed
US-4092431-A ANTIULCER AGENTS, GASTROINTESTINAL DISORDERS CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1978-05-30 US claimed
US-4058523-A ANTIULCER, VASODILATION, HYPOTENSIVE, ANALGESIC CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-11-15 US claimed
US-4038416-A PREVENTION AND TREATMENT OF GASTRITIS AND PEPTIC ULCER CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-07-26 US claimed
JP-51125242-A None JP disclosed
US-20230194486-A1 QUANTITATIVE CHIRALITY AND CONCENTRATION SENSING OF CHIRAL ANALYTES USING A RELAY ASSAY NATIONAL SCIENCE FOUNDATION 2023-06-22 US disclosed
US-20230194486-A1 QUANTITATIVE CHIRALITY AND CONCENTRATION SENSING OF CHIRAL ANALYTES USING A RELAY ASSAY NATIONAL SCIENCE FOUNDATION 2023-06-22 US disclosed
US-9896465-B2 Phosphonium compound, preparation method thereof, epoxy resin composition including the same, and semiconductor device prepared by using the same SAMSUNG SDI CO., LTD. (KR) 2018-02-20 US disclosed
US-9870971-B2 Epoxy resin composition for encapsulating a semiconductor device and semiconductor device prepared using the same SAMSUNG SDI CO., LTD. (KR) 2018-01-16 US disclosed
US-9850390-B2 Epoxy resin composition for encapsulating semiconductor device and semiconductor device prepared using the same SAMSUNG SDI CO., LTD. (KR) 2017-12-26 US disclosed
US-20170002192-A1 EPOXY RESIN COMPOSITION FOR ENCAPSULATING A SEMICONDUCTOR DEVICE AND SEMICONDUCTOR DEVICE PREPARED USING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-05 US disclosed
US-4092431-A ANTIULCER AGENTS, GASTROINTESTINAL DISORDERS CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1978-05-30 US disclosed
US-4092431-A ANTIULCER AGENTS, GASTROINTESTINAL DISORDERS CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1978-05-30 US disclosed
US-4058523-A ANTIULCER, VASODILATION, HYPOTENSIVE, ANALGESIC CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-11-15 US disclosed
US-4058523-A ANTIULCER, VASODILATION, HYPOTENSIVE, ANALGESIC CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-11-15 US disclosed
US-4058523-A ANTIULCER, VASODILATION, HYPOTENSIVE, ANALGESIC CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-11-15 US disclosed
US-4038416-A PREVENTION AND TREATMENT OF GASTRITIS AND PEPTIC ULCER CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-07-26 US disclosed
US-4038416-A PREVENTION AND TREATMENT OF GASTRITIS AND PEPTIC ULCER CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) 1977-07-26 US disclosed
JP-S51125242-A PROCESS FOR PREPARING BIS-(BENZAMIDO)- BENZENE DERIVATIVES CHUGAI PHARMACEUT CO LTD 1976-11-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368937-A1 PHOSPHONIUM COMPOUND, PREPARATION METHOD THEREOF, EPOXY RESIN COMPOSITION INCLUDING THE SAME, AND SEMICONDUCTOR DEVICE PREPARED BY USING THE SAME PHOSPHO1, PPA1, ASH2L MDM4 1897/4885TP53 3257/4885HDAC3 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.